Laura Wisniewski

Assessing Public Perception and Risk Communication of Climate Change Impacts

Laura Wisniewski, Carla Bianchi, Kasper Benitez

Public perception of climate change and the effectiveness of risk communication strategies play a critical role in shaping societal responses to environmental threats. This study examines how different demographic groups perceive climate risks and evaluates the impact of various communication approaches on …

Afrique du Sud, ru, Tunisie (code pays fourni par la source)

Assessing Public Perception and Risk Communication of Climate Change Impacts

Laura Wisniewski, Carla Bianchi, Kasper Benitez

Public perception of climate change and the effectiveness of risk communication strategies play a critical role in shaping societal responses to environmental threats. This study examines how different demographic groups perceive climate risks and evaluates the impact of various communication approaches on …

Afrique du Sud, ru, Tunisie (code pays fourni par la source)

Treatment with αvβ3-integrin-specific 29P attenuates pressure-overload induced cardiac remodelling after transverse aortic constriction in mice

Alexandra Njegić, Lina Laid, Min Zi, Eleni Maniati et autres

Heart failure remains one of the largest clinical burdens globally, with little to no improvement in the development of disease-eradicating therapeutics. Integrin targeting has been used in the treatment of ocular disease and cancer, but little is known about its utility in …

gb, il, de (code pays fourni par la source)

Data from Suppression of Endothelial Cell FAK Expression Reduces Pancreatic Ductal Adenocarcinoma Metastasis after Gemcitabine Treatment

Marina Roy-Luzarraga, Louise E. Reynolds, Beatriz de Luxán‐Delgado, Óscar Maiques et autres

Abstract Despite substantial advances in the treatment of solid cancers, resistance to therapy remains a major obstacle to prolonged progression-free survival. Pancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive cancers, with a high level of liver metastasis. Primary PDAC is …

Supplementary Figure from Suppression of Endothelial Cell FAK Expression Reduces Pancreatic Ductal Adenocarcinoma Metastasis after Gemcitabine Treatment

Marina Roy-Luzarraga, Louise E. Reynolds, Beatriz de Luxán‐Delgado, Óscar Maiques et autres

Supplementary Figure from Suppression of Endothelial Cell FAK Expression Reduces Pancreatic Ductal Adenocarcinoma Metastasis after Gemcitabine Treatment

Supplementary Figure from Suppression of Endothelial Cell FAK Expression Reduces Pancreatic Ductal Adenocarcinoma Metastasis after Gemcitabine Treatment

Marina Roy-Luzarraga, Louise E. Reynolds, Beatriz de Luxán‐Delgado, Óscar Maiques et autres

Supplementary Figure from Suppression of Endothelial Cell FAK Expression Reduces Pancreatic Ductal Adenocarcinoma Metastasis after Gemcitabine Treatment

Supplementary Figure from Suppression of Endothelial Cell FAK Expression Reduces Pancreatic Ductal Adenocarcinoma Metastasis after Gemcitabine Treatment

Marina Roy-Luzarraga, Louise E. Reynolds, Beatriz de Luxán‐Delgado, Óscar Maiques et autres

Supplementary Figure from Suppression of Endothelial Cell FAK Expression Reduces Pancreatic Ductal Adenocarcinoma Metastasis after Gemcitabine Treatment

Supplementary Figure from Suppression of Endothelial Cell FAK Expression Reduces Pancreatic Ductal Adenocarcinoma Metastasis after Gemcitabine Treatment

Marina Roy-Luzarraga, Louise E. Reynolds, Beatriz de Luxán‐Delgado, Óscar Maiques et autres

Supplementary Figure from Suppression of Endothelial Cell FAK Expression Reduces Pancreatic Ductal Adenocarcinoma Metastasis after Gemcitabine Treatment

Supplementary Figure from Suppression of Endothelial Cell FAK Expression Reduces Pancreatic Ductal Adenocarcinoma Metastasis after Gemcitabine Treatment

Marina Roy-Luzarraga, Louise E. Reynolds, Beatriz de Luxán‐Delgado, Óscar Maiques et autres

Supplementary Figure from Suppression of Endothelial Cell FAK Expression Reduces Pancreatic Ductal Adenocarcinoma Metastasis after Gemcitabine Treatment

Supplementary Data from Suppression of Endothelial Cell FAK Expression Reduces Pancreatic Ductal Adenocarcinoma Metastasis after Gemcitabine Treatment

Marina Roy-Luzarraga, Louise E. Reynolds, Beatriz de Luxán‐Delgado, Óscar Maiques et autres

Supplementary Data from Suppression of Endothelial Cell FAK Expression Reduces Pancreatic Ductal Adenocarcinoma Metastasis after Gemcitabine Treatment

Supplementary Figure from Suppression of Endothelial Cell FAK Expression Reduces Pancreatic Ductal Adenocarcinoma Metastasis after Gemcitabine Treatment

Marina Roy-Luzarraga, Louise E. Reynolds, Beatriz de Luxán‐Delgado, Óscar Maiques et autres

Supplementary Figure from Suppression of Endothelial Cell FAK Expression Reduces Pancreatic Ductal Adenocarcinoma Metastasis after Gemcitabine Treatment

Supplementary Figure from Suppression of Endothelial Cell FAK Expression Reduces Pancreatic Ductal Adenocarcinoma Metastasis after Gemcitabine Treatment

Marina Roy-Luzarraga, Louise E. Reynolds, Beatriz de Luxán‐Delgado, Óscar Maiques et autres

Supplementary Figure from Suppression of Endothelial Cell FAK Expression Reduces Pancreatic Ductal Adenocarcinoma Metastasis after Gemcitabine Treatment